Gen-Probe, Affy Provide Updates at Conference | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe and Affymetrix presented updates on their businesses for investors at the Thomas Weisel Healthcare Conference being held this week in Boston.

Gen-Probe officials said that the firm is on track with clinical trials for its Aptima HPV assay and expects to file for US Food and Drug Administration clearance of the test by the end of 2010. They also said that Panther, Gen-Probe's fully automated molecular instrument, is on schedule for a late 2010 launch in Europe, followed by a US launch in 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.